4//SEC Filing
Lee Sung 4
Accession 0001628280-24-006983
CIK 0001706431other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:32 PM ET
Size
6.9 KB
Accession
0001628280-24-006983
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-22+40,000→ 106,500 total - Award
Stock Option (Right to Buy)
2024-02-22+80,000→ 80,000 totalExercise: $10.11Exp: 2034-02-21→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001793200
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:32 PM ET
- Size
- 6.9 KB